Klinikum Chemnitz gGmbH; Klinik f. Innere Medizin III

Chemnitz 09116

0 studies enrolling now · 3 studies all time

What they study most

Follicular Lymphoma, Large B-Cell Lymphoma, Multiple Myeloma, Plasma Cell Disorder

Studies at this site

• Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma — Recruiting now
• An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma — Running, not enrolling
• A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL) — Completed